These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 11593432
1. Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging. Gozuacik D, Murakami Y, Saigo K, Chami M, Mugnier C, Lagorce D, Okanoue T, Urashima T, Bréchot C, Paterlini-Bréchot P. Oncogene; 2001 Sep 27; 20(43):6233-40. PubMed ID: 11593432 [Abstract] [Full Text] [Related]
2. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B]. Tu H, Gao HF, Ma GH, Liu Y. Zhonghua Yi Xue Za Zhi; 2006 May 16; 86(18):1249-52. PubMed ID: 16796883 [Abstract] [Full Text] [Related]
3. Alteration of gene expression in human hepatocellular carcinoma with integrated hepatitis B virus DNA. Tamori A, Yamanishi Y, Kawashima S, Kanehisa M, Enomoto M, Tanaka H, Kubo S, Shiomi S, Nishiguchi S. Clin Cancer Res; 2005 Aug 15; 11(16):5821-6. PubMed ID: 16115921 [Abstract] [Full Text] [Related]
4. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan. Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S. J Med Virol; 2003 Dec 15; 71(4):492-8. PubMed ID: 14556260 [Abstract] [Full Text] [Related]
5. Hepatitis B virus as an insertional mutagene in a human hepatocellular carcinoma. Dejean A, de Thé H. Mol Biol Med; 1990 Jun 15; 7(3):213-22. PubMed ID: 2170809 [Abstract] [Full Text] [Related]
6. Characterization of integration patterns and flanking cellular sequences of hepatitis B virus in childhood hepatocellular carcinomas. Tsuei DJ, Chang MH, Chen PJ, Hsu TY, Ni YH. J Med Virol; 2002 Dec 15; 68(4):513-21. PubMed ID: 12376959 [Abstract] [Full Text] [Related]
7. Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis. Minami M, Daimon Y, Mori K, Takashima H, Nakajima T, Itoh Y, Okanoue T. Oncogene; 2005 Jun 23; 24(27):4340-8. PubMed ID: 15806150 [Abstract] [Full Text] [Related]
8. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Murakami Y, Saigo K, Takashima H, Minami M, Okanoue T, Bréchot C, Paterlini-Bréchot P. Gut; 2005 Aug 23; 54(8):1162-8. PubMed ID: 16009689 [Abstract] [Full Text] [Related]
9. [Relationship between mutation on precore region of integrated HBV DNA and p53 gene mutation in hepatocellular carcinoma]. Wang XH, Wang PL. Ai Zheng; 2003 Jul 23; 22(7):715-8. PubMed ID: 12866962 [Abstract] [Full Text] [Related]
10. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags. Yoon SY, Kim JM, Oh JH, Jeon YJ, Lee DS, Kim JH, Choi JY, Ahn BM, Kim S, Yoo HS, Kim YS, Kim NS. Int J Oncol; 2006 Aug 23; 29(2):315-27. PubMed ID: 16820872 [Abstract] [Full Text] [Related]
11. Sequencing of human-viral DNA junctions in hepatocellular carcinoma from patients with HCV and occult HBV infection. Tamori A, Nishiguchi S, Kubo S, Enomoto M, Koh N, Takeda T, Shiomi S, Hirohashi K, Kinoshita H, Otani S. J Med Virol; 2003 Apr 23; 69(4):475-81. PubMed ID: 12601754 [Abstract] [Full Text] [Related]
12. Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray. Iizuka N, Oka M, Yamada-Okabe H, Hamada K, Nakayama H, Mori N, Tamesa T, Okada T, Takemoto N, Matoba K, Takashima M, Sakamoto K, Tangoku A, Miyamoto T, Uchimura S, Hamamoto Y. Int J Oncol; 2004 Mar 23; 24(3):565-74. PubMed ID: 14767541 [Abstract] [Full Text] [Related]
13. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries. Ding X, Park YN, Taltavull TC, Thung SN, Jin X, Jin Y, Trung NS, Edamoto Y, Sata T, Abe K. Jpn J Infect Dis; 2003 Feb 23; 56(1):12-8. PubMed ID: 12711820 [Abstract] [Full Text] [Related]
14. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S, Nakashima Y, Kojiro M, Tabor E. J Viral Hepat; 2005 May 23; 12(3):325-9. PubMed ID: 15850475 [Abstract] [Full Text] [Related]
15. HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer. Shamay M, Agami R, Shaul Y. Oncogene; 2001 Oct 18; 20(47):6811-9. PubMed ID: 11687960 [Abstract] [Full Text] [Related]
16. The correlation of hepatitis B virus pre-S mutation with cellular oxidative DNA damage in hepatocellular carcinoma. Gwak GY, Lee DH, Moon TG, Choi MS, Lee JH, Koh KC, Paik SW, Park CK, Joh JW, Yoo BC. Hepatogastroenterology; 2008 Oct 18; 55(88):2028-32. PubMed ID: 19260471 [Abstract] [Full Text] [Related]
17. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma. Tharayil VS, Roberts LR. Minerva Gastroenterol Dietol; 2006 Dec 18; 52(4):387-406. PubMed ID: 17108869 [Abstract] [Full Text] [Related]
18. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Paterlini-Bréchot P, Bréchot C, Kremsdorf D. Cancer Res; 2001 Nov 01; 61(21):7803-10. PubMed ID: 11691796 [Abstract] [Full Text] [Related]
19. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America. Hsia CC, Scudamore CH, Di Bisceglie AM, Tabor E. J Med Virol; 2003 May 01; 70(1):20-6. PubMed ID: 12629639 [Abstract] [Full Text] [Related]
20. [X protein variations of genotype B and C hepatitis B virus isolated from the patients with hepatocellular carcinoma]. Xu X, Chen WN, Zheng DL, Huang QL, Lin X. Ai Zheng; 2004 Jul 01; 23(7):756-61. PubMed ID: 15248907 [Abstract] [Full Text] [Related] Page: [Next] [New Search]